Neutrophile myeloperoxidase, protective enzyme with strong oxidative activities;La myéloperoxydase des neutrophiles, une enzyme de défense aux capacités oxydantes

Annales de Medecine Veterinaire

Volumn 147, Issue 2, 2003, Pages 79-93

  Serteyn, D ^a,b   Grulke, S ^a,b   Franck, T ^b   Mouithys Mickalad, A ^b   Deby Dupont, G ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Ctr de l'Oxygene Rech et Devmt   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; MYELOPEROXIDASE;

BACTERICIDAL ACTIVITY; CELL ACTIVATION; CHLORINATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME RELEASE; IMMUNOLOGICAL TECHNIQUE; LYSOSOME; NEUTROPHIL; OXIDATION; PROTECTION; REVIEW;

EID: 0242321934     PISSN: 00034118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (164)

1. ABU-SOUD H.M., HAZEN S.L. Nitric oxide modulates the catalytic activity of myeloperoxidase. J. Biol. Chem., 2000a, 275, 5425-5430.
2. ABU-SOUD H.M., HAZEN S.L. Nitric oxide is a physiololgical substrate for mammalian peroxidases. J. Biol. Chem., 2000b, 275, 37524-37532.
3. AGNER K. Verdoperoxidase. A ferment isolated from leucocytes. Acta Physiol. Scand., 1941, 2(suppl 8), 1-62.
4. ALLEN D., TYLER D.A. Pathophysiology of acute abdominal disease. In : White N.A.( ed.), The equine acute abdomen, Lea & Febiger : Philadelphia, 1990, 65-89.
5. ARNDT H., KUBES P., GRANGER D.N. Involvement of neutrophils in ischemia-reperfusion injury in the small intestine. Klin. Wochenschr., 1991, 69, 1056-1060.
6. AUSTIN G.E., ZHAO W.G., REGNI A., LU J.P., BRAUN G.E. Identification of an upstream enhancer containing an AML1 site in the human myeloperoxidase (MPO) gene. Leuk. Res., 1998, 22, 1037-1048.
7. BABIOR B.M. NADPH Oxidase: An update. Blood, 1999, 93, 1464-1476.
8. BABIOR B.M. Phagocytes and oxidative stress. Am. J. Med., 2000, 109, 33-44.
9. BAKKENIST A.R.J., WEVER R., VULSMA T., PLAT H., VAN GELDER B.F. Isolation procedure and some properties of myeloperoxidase from human leukocytes. Biochim. Biophys. Acta, 1978, 524, 45-54.
10. BARCLAY W.P., FOERNER J.J., PHILLIPS T.N. Volvulus of the large colon in the horse. J. Am. Vet. Med. Assoc., 1980, 177, 629-630.
11. BARKER I.K., VAN DREUMEL A.A. The alimentary system. In: Jubb W., Kennedy P.C., Palmer N. (eds), Pathology of domestic animals. Academic Press : New York 1985, 60-66.
12. BENBAREK H., GRULKE S., DEBY-DUPONT G., DEBY C., MATHY-HARTERT M., CAUDRON I., DESSY-DOIZE C., LAMY M., SERTEYN D. Cytotoxicity of stimulated equine neutrophils on equine endothelial cells in culture. Equine Vet. J., 2000, 4, 327-333.
13. BORREGAARD N., COWLAND J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 1997, 89, 3503-3521.
14. BOSCH X., MIRAPEIX E., FONT J., INGELMO M., REVERT L. Anti-myeloperoxidase antibodies in crescentic glomerulonephritis. Nephron, 1991, 59, 504-505.
15. BOSCH X., FONT J., MIRAPEIX E., REVERT L., INGELMO M., URBANO-MARQUEZ A. Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis. Am. Rev. Respir. Dis., 1992, 146, 1326-1329.
16. CARR A.C., VAN DEN BERG J.M., WINTERBOURN C.C. Differential reactivities of hypochlorous and hypobromous acids with purified Escherichia coli phospholipid: formation of haloamines and halohydrins. Biochim. Biophys. Acta, 1998, 1392, 254-264.
17. CARR A.C., MYZAK M.C., STOCKER R., MCCALL M.R., FREI B. Myeloperoxidase binds to low density lipoprotein : potential implications for atherosclerosis. FEBS Lett., 2000, 487, 176-180.
18. CARR A.C., HAWKINS C., THOMAS S.R., STOCKER R., FREI B. Relative reactivities of N-chloramines and hypochlorous acid with human plasma constituents. Free Radic. Biol. Med., 2001, 30, 526-536.
19. CECH P., LEHRER R.I. Phagolysosomal pH of human neutrophils. Blood, 1984, 63, 88-91.
20. COCHRANE C.G., SPRAGG R.G., REVAK S.D., COHEN A.B., MCGUIRE W.W. The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluids of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis., 1983, 127, 525-527.
21. COORAY R., PETERSON C.G.B., HOLMOBERG O. Isolation and purification of bovine myeloperoxidase from neutrophil granules. Vet. Immunol. Immunopathol., 1993, 38, 261-272.
22. DAUGHERTY A., DUNN J.L., RATERI D.L., HEINECKE J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest., 1994, 94, 437-444.
23. DEBY-DUPONT G., GRÜLKE S., CAUDRON I., MATHY-HARTERT M., BENBAREK H., DEBY C., LAMY M., SERTEYN D. Equine myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies. Vet. Immunol. Immunopathol. 1998, 66, 257-271.
24. DELEO F.R., GOEDKEN M., MCCORMICK S.J., NAUSEEf W.M. A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/ proteasome degradation. J. Clin. Invest., 1998, 101, 2900-2909.
25. DUNFORD H.B. Peroxidase-catalyzed halide ion oxidation. Redox Report, 2000, 5, 169-171.
26. EDWARDS S.W., NURCOMBE H.L., HART C.A. Oxidative inactivation of myeloperoxidase released from neutrophils. Biochem. J., 1987, 245, 925-930.
27. EHRENBERG A., AGNER K. The molecular weight of myeloperoxidase. Acta Chem. Scand., 1958, 12, 95-100.
28. EISERICH J.P., HRISTOVA M., CROSS C.E., JONES A.D., FREEMAN B.A., HALLIWELL B., VAN DER VLIET A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature, 1998, 391, 393-397.
29. EL-HAG A., CLARK R.A. Immunosuppression by activated human neutrophils. J. Immunol., 1987, 139, 2406-2413.
30. ENGELMANN I., DORMANN S., SARAN M., BAUER G. Transformed target cell-derived superoxide anions drive apoptosis induction by myeloperoxidase. Redox Report, 2000, 5, 207-214.
31. FAYMONVILLE M.E., PINCEMAIL J., DUCHATEAU J., PAULUS J.M., ADAM A., DEBY-DUPONT G., DEBY C., ALBERT A., LARBUISSON R., LIMET R., LAMY M. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J. Thorac. Cardiovasc. Surg., 1991, 102, 309-317.
32. FENNA R., ZENG J., DAVEY C. Structure of the green heme in myeloperoxidase. Arch. Biochem; Biophys., 1995, 316, 653-656.
33. FERRARI S., TAGLIAFICO E., CECCHERELLI G., SELLERI L., CALABRETTA B., DONELLI A., TEMPERANI P., SARTI M., SACCHI S., EMILIA G. Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias : relationship to the expression of cell cycle-related genes. Leukemia, 1989, 3, 423-430.
34. FIEDLER T.J., DAVEY C.A., FENNA R.E. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 Å resolution. J. Biol. Chem., 2000, 275, 11964-11971.
35. FLORIS R., WEVER R. Reaction of myeloperoxidase with its product HOC1. Eur. J. Biochem., 1992, 207, 697-702.
36. FU X., KASSIM S.Y., PARKS W.C., HEINECKE J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem., 2001, 27, 41279-41287.
37. FURTMÜLLER P.G., BURNER U., JANTSCHKO W., REGELSBERGER G., OBINGER C. The reactivity of myeloperoxidase compound I formed with hypochlorous acid. Redox Report, 2000a, 5, 173-178.
38. FURTMÜLLER P.G., OBINGER C., HSUANYU Y., DUNFORD H.B. Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride anion. Eur. J. Biochem., 2000b, 267, 5858-5864.
39. GAUT J.P., YEH TG.C., DUY TRAN H., BYUN J., HENDERSON J.P., RICHTER G.M., BRENNAN M.L., LUSIS A.J., BELAAOUAJ A., HOTCHKISS R.S., HEINECKE J.W. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci., 2001, 98, 11961-11966.
40. GERBER C.E., KUCI S., ZIPFEL M., NIETHAMMER D., BRUCHELT G. Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency. Eur. J. Clin. Chem. Clin. Biochem., 1996, 34, 901-908.
41. GERRITY R.G. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol., 1981, 103, 181-190.
42. GREEN E.M., ADAMS R. New perspectives in circulatory shock: pathophysiologic mediators of the mammalian response to endotoxemia and sepsis. J. Am. Vet. Med. Assoc., 1992, 200, 1834-1841.
43. GRIENDLING K.K., SORESCU D., USHIO-FUKAI M. NAD(P)H Oxidase : role in cardiovascular biology and disease. Circ. Res., 2000, 86, 494-501.
44. GRÜLKE S. Les obstructions intestinales chirurgicales chez le cheval: approche clinique, activation leucocytaire et étude du pancréas. Thèse de Doctorat en Sciences Vété rinaires, Université de Liège, 2002, 298 pages.
45. GRÜLKE S., BENBAREK H., CAUDRON I., DEBYDUPONT C., MATHY-HARTERT M., FARNIR F., DEBY C., LAMY M., SERTEYN D. Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestine obstruction requiring surgery: preliminary results. Can. J. Vet. Res., 1999, 63, 142-147.
46. HAMPTON M.B., KETTLE A.J., WINTERBOURN C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood, 1998, 92, 3007-3017.
47. HARRISON JE, PABALAN S, SCHULTZ J. The subunit structure of crystalline canine myeloperoxidase. Biochem Biophys Acta 1977, 493, 247-259.
48. HAWKINS C.L., DAVIES M.J. Hypochlorite-induced damage to proteins : formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem. J., 1998, 332, 617-625.
49. HAZELL L.J., STOCKER R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of lipoprotein into a high-uptake form for macrophages. Biochem. J., 1993, 290, 165-172.
50. HAZELL L.J., ARNOLD L., FLOWERS D., WAEG G., MALLE E., STOCKER R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest., 1996, 87, 1535-1544.
51. HAZEN S.L., HSU F.F., DUFFIN K., HEINECKE J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a familly of chlorinated sterols. J. Biol. Chem., 1996a, 271, 23080-23088.
52. HAZEN S.L., HSU F.F., MUELLER D.M., CROWLEY J.R., HEINECKE J.W. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest., 1996b, 98, 1283-1289.
53. HAZEN S.L., HEINECKE J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed chlorination is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest., 1997, 99, 2075-2081.
54. HAZEN S.L., D'AVIGNON A., ANDERSON M.M., HSU F.F., HEINECKE J.W. Human neutrophils employ the myeloperoxidase-H2O2-Cl-system to oxidize-amino acids to a family of reactive aldehydes: mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem., 1998a, 273, 4997-5005.
55. HAZEN S.L., HSU F.F., D'AVIGNON A., HEINECKE J.W. Human neutrophils employ myeloperoxidase to convert alpha-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry, 1998b, 37, 6864-6873.
56. HELLER J.I., CROWLEY J.R., HAZEN S.L., SALVAY D.M., WAGNER P., PENNATHUR S. p-Hydroxyphenylacetaldehyde, an aldehyde generated by myloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J. Biol. Chem., 2000, 275, 9957-9962.
57. HIMMELHOCH R.S., EVANS W.H., MAGE M.G., PETERSON E.A. Purification of myeloperoxidase from the bone marrow of the guinea pig. Biochemistry, 1969, 8, 914-921.
58. HOLLAND J.A., O'DONNELL R.W., CHANG M.M., JOHNSON D.K., ZIEGLER L.M. Endothelial cell oxidant production : effect of NADPH oxidase inhibitors. Endothelium, 2000, 7, 109-119.
59. HOY A., LEININGER-MULLER B., KUTTER D., SIEST G., VISVIKIS S. Growing significance of myeloperoxidase in non-infectious diseases. Clin. Chem. Lab. Med., 2002, 40, 2-8.
60. HU, ML., LOUIE, S., CROSS C.E., MOTCHNIK, P., HALLIWELL, B. Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med., 1993, 121, 257-262.
61. INAZAWA J., INOUE K., NISHIGAKI H., TSUDA S., TANIWAKI M., MISAWA S., ABE T. Assignment of the human myeloperoxidase gene (MPO) to bands q21. 3-----q23 of chromosome 17. Cytogenet. Cell. Genet., 1989, 50, 135-136.
62. IRANI K. Oxidant signaling in vascular cell growth, death, and survival. Circ. Res., 2000, 87, 179-183.
63. JACQUET A., DEBY C., MATHY M., MOGUILEWSKY N., DEBY-DUPONT G., THIRION A., GOORMAGHTIGH E., GARCIA-QUINTANA L., BOLLEN A., PINCEMAIL J. Spectral and enzymatic properties of human recombinant myeloperoxidase : comparison with the mature enzyme. Arch. Biochem. Biophys., 1991, 291, 132-138.
64. JERLICH A., FABJAN J.S., TSCHABUSCHNIG S., SMIRNOVA A., HORAKOVA L., HAYN M., AUER H., GUTTENBERGER H., LEIS H.J., TATZBER F., WAEG G., SCHAUR R.J. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase. Free Radic. Biol. Med., 1998, 24, 1139-1148.
65. JOHNSON K., GEMPERLEIN I., HUDSON S., SHANE S., ROVERA G. Complete nucleotide sequence of the human myeloperoxidase gene. Nucleic Acids Res., 1989, 17, 7985-7986.
66. KANTARCI O.H., LESNICK T.G., YANG P., MEYER R.L., HEBRINK D.D., MCMURRAY C.T., WEINSHENKER B.G. Myeloperoxidase -463 (G◇A) polymorphism associated with lower risk of lung cancer. Mayo Clin. Proc., 2002, 77, 17-22.
67. KARLSSON A., DAHLGREN C. Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid. Redox Signal, 2002, 4, 49-60.
68. KARNOFSKY J.R., WRIGHT J., MILES-RICHARDSON G.E., TAUBER A. Biochemical requirements for singlet oxygen production by purified human myeloperoxidase. J. Clin. Invest., 1984, 74, 1489-1495.
69. KETTLE A.J., WINTERBOURN C.C. Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode. Biochem. J., 1989, 263, 823-828.
70. KETTLE A.J., WINTERBOURN C.C. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Report, 1997, 3, 3-15.
71. KETTLE A.J., CANDAEIS L.P. Oxidation of tryptophan by redox intermediates of myeloperoxidase and inhibition of hypochlorous acid production. Redox Report, 2000, 5, 179-184.
72. KETTLE A.J. Neutrophils convert tyrosin residues in albumin to chlorotyrosine. FEBS Lett., 2000, 379, 103-106.
73. KING C.C., JEFFERSON M.M., THOMAS E.L. Secretion and inactivation of myeloperoxidase by isolated neutrophils. J. Leukoc. Biol., 1997, 61, 293-302.
74. KIZAKI M., MILLER C.W., SELSTED M.E., KOEFFLER H.P. Myeloperoxidase (MPO) gene mutation in hereditary MPO deficiency. Blood, 1994, 83, 1935-1940.
75. KLEBANOFF S.J., CLARK R.A. Hemolysis and iodination of erythrocyte components by a myeloperoxidase-mediated system. Blood, 1975, 45, 699-707.
76. KLEBANOFF S.J. Myeloperoxidase. Proc. Assoc. Am. Physicians, 1999, 111, 383-389.
77. KOOTER I.M., MOGUILEVSKY N., BOLLEN A., VAN DER VEEN L.A., OTTO C., DEKKER H.L., WEVER R. The sulfonium ion linkage in myeloperoxidase. Direct spectroscopic detection by isotopic labeling and effect of mutation. J. Biol. Chem., 1999, 274, 26794-26802.
78. LAMB N.J., QUINLAN G.J., WESTERMAN S.T., GUTTERIDGE J.M.C., EVANS T.W. Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am. J. Respir. Crit. Care Med., 1999, 160, 1031-1034.
79. LEFKOWITZ D.L., MILLS K., MORGAN M., LEFKOWITZ S. Macrophage activation and immuno-modulation by myeloperoxidase. Proc. Soc. Exp. Biol. Med., 1992, 199, 204-210.
80. LINCOLN J.A., LEFKOWITZ D.L., CAIN T., CASTRO A., MILLS K.C., LEFKOWITZ S.S., MOGUILEVSKY N., BOLLEN A. Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. Infect. Immun., 1995, 63, 3042-3047.
81. LOCKSEY R.M., NELSON C., FANKHAUSER J.E., KLEBANOFF S.J. Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity. Am. J. Trop. Med. Hyg., 1987, 36, 541-548.
82. LONDON S.J., LEHMAN T.A., TAYLOR J.A. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res., 1997, 57, 5001-5003.
83. LONGHURST C., EHRENSTEIN M.R., LEAKER B., STEVENSON F.K., SPELLERBERG M., CHAPMAN C., LATCHMEN D., ISENBERG D.A., CAMBRIDGE G. Analysis of immunoglobin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis. Immunology, 1996, 87, 334-338.
84. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur. J. Biochem., 2000, 267, 4495-4503.
85. MATHESON N.R., WONG P.S., TRAVIS J. Isolation and properties of human myeloperoxidase. Biochemistry, 1981, 20, 325-330.
86. MATHY-HARTERT M., DEBY-DUPONT G., DEBY C., JADOUL L., VANDENBERGHE A., LAMY M. Cytotoxicity induced by neutrophil myeloperoxidase towards human endothelial cells : protection by ceftazidime. Mediat. Inflamm., 1995, 4, 1-7.
87. MATHY-HARTERT M., DEBY-DUPONT G., MELIN P., LAMY M., DEBY C. Cultured macrophages acquire a bactericidal activity against Pseudomonas aeruginosa after incorporation of myeloperoxidase. Experientia, 1996, 52, 1-8.
88. MATHY-HARTERT M., BOURGEOIS E., GRÜLKE S., DEBY-DUPONT G., CAUDRON I., DEBY C., LAMY M., SERTEYN D. Purification of myeloperoxidase from equine polymorphonuclear leucocytes. Can. J. Vet. Res., 1998, 62, 127-132.
89. MATHY-HARTERT M., DAMAS P., NYS M., DEBY-DUPONT G., CANNIVET J.L., LEDOUX D., LAMY M. Nitrotyrosine proteins in bronchoalveolar lavage fluid of intensive care patients at risk of ventilator-associated bronchopneumonia. Eur. Respir. J., 2000, 16, 296-301.
90. MCCONNICO R.S., WEINSTOCK D., POSTON M.E., ROBERTS M.C. Myeloperoxidase activity of the large intestine in an equine model of acute colitis. Am. J. Vet. Res., 1999, 60, 807-813.
91. MEYER J.M., HOLLAND J.A., ZIEGLER L.M., CHANG M.M., BEEBE G., SCHMITT M.E. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells : a potential atherogenic souce of reactive oxygen species. Endothelium, 1999, 7, 11-22.
92. MIYASAKI K.T., WILSON M.E., COHEN E., JONES P.C., GENCO R.J. Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase. Arch. Biochem. Biophys., 1986, 246, 751-764.
93. MOGUILEVSKY N., GARCIA-QUINTANA L., JACQUET A., TOURNAY C., FABRY L., PIÉRARD L., BOLLEN A. Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell lines. Eur. J. Biochem., 1991, 197, 605-614.
94. MOORE J.N., MORRIS D.D. Endotoxemia and septicemia in horses: experimental and clinical correlates. J. Am. Vet. Med. Assoc., 1992, 200, 1903-1914.
95. MOORE R.M., BERTONE A.L., BAILEY M.Q., MUIR W.W., BEARD W.L. Neutrophil accumulaton in the large colon of horses during low-flow ischemia and reperfusion. Am. J. Vet. Res., 1994, 55, 1454-1463.
96. MORISHITA K., KUBOTA N., ASANO S., KAZIRO Y., NAGATA S. Molecular cloning and characterization of cDNA for human myeloperoxidase. J. Biol. Chem., 1987, 262, 3844-3851.
97. MORRIS D.D. Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis. J. Vet. Int. Med., 1991, 5, 167-181.
98. MYZAK M.C., CARR A.C. Myeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells : protection by the antioxidants ascorbate and (dihydro)lipoic acid. Redox Report, 2002, 7, 47-53.
99. NAGRA R.M., BECHER B., TOURTELLOTTE W.W., ANTEL J.P., GOLD D., PALADINO T., SMITH R.A., NELSON J.R., REYNOLDS W.F. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol., 1997, 78, 97-107.
100. NAUSEEF W.M. Myeloperoxidase deficiency. Hemat. Oncol. Clin North. Am., 1988, 2, 135-158.
101. NAUSEEF W.M., OLSSON I., ARNLJOTS K. Biosynthesis and processing of myeloperoxidase: a marker of myeloid cell differentiation. Eur. J. Haematol., 1988, 40, 97-110.
102. NAUSEEF W.M., COGLEY M., MCCORMICK S. Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J. Biol. Chem., 1996, 271, 9546-9549.
103. NAUSEEF W.M., MCCORMICK S., GOEDKEN M. Impact of missense mutations on biosynthesis of myeloperoxidase. Redox Report, 2000, 5, 197-206.
104. NAUSEEF W.M. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int. J. Hematol., 2001, 74, 125-133.
105. NISHIZAWA H., YAMAMDA H., MIYAZAKI H., OHARA M., KANEKO K., YAMAKAWA T. WIENERKRONISH J., KUDOH I. Soluble complement receptor type 1 inhibited the systemic organ injury caused by acid instillation into a lung. Anesthesiology, 1996, 85, 1120-1128.
106. NYS M., DEBY-DUPONT G., HABRAKEN Y., LEGRAND-POELS S., KOHNEN S., LEDOUX D., CANIVET JL., DAMAS P., LAMY M. Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate the NF-kappaB transcription factor in a human epithelial alveolar cell line. Clinical Science, 2002, 103, 577-585.
107. OLSSON I., PERSSON A.M., STRÖMBERG K. Biosynthesis, transport and processing of myeloperoxidase in the human leukæmic promyelocytic cell line HL-60 and normal marrow cells. Biochem. J., 1984, 223, 911-920.
108. PASCOE P.J., MCDONELL W.N., TRIM C.M., VAN GORDER J. Mortality rates and associated factors in equine colic operations - A retrospective study of 341 operations. Can. J. Vet., 1983, 24, 76-85.
109. PAUL K., BAUER G. Promyelocytic HL-60 cells induce apoptosis selectively in transformed cells : involvement of myeloperoxidase, nitric oxide and target cell-derived superoxide anions. Anticancer. Res., 2001, 21, 3237-3246.
110. PEPPIN G.J., WEISS S.J. Activation of endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. USA, 1986, 83, 4322-4326.
111. PETRIDES P.E. Molecular genetics of peroxidase deficiency. J. Mol. Med., 1998, 76, 688-698.
112. PODREZ E.A., ABU-SOUD H.M., HAZEN S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med., 2000, 28, 1717-1725.
113. RADI R., PELUFFO G., ALVAREZ M.N., NAVILIAT M., CAYOTA A. Unraveling peroxynitrite formation in biological system. Free Radic. Biol. Med., 2001, 30, 463-488.
114. RAKITA R.M., MICHER B.R., ROSEN H. Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry, 1990, 29, 1075-1080.
115. REYNOLDS W.F., RHEES J., MACIEJEWSKI D., PALADINO T., SIEBURG H., MAKI R.A., MASLIAH E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol., 1999, 155, 31-41.
116. RIFKIND J.M., ABUGO O., LEVY A., HEIM J. Detection, formation and relevance of hemichromes and hemochromes. Methods Enzymol., 1994, 231, 449-480.
117. ROMANO M., DRI P., DADALT L., PATRIARCA P., BARALLE F.E. Biochemical and molecular characterization of hereditary myeloperoxidase deficiency. Blood, 1997, 90, 4126-4134.
118. 2-halide antimicrobial system. Infect. Immun., 1985, 47, 613-618.
119. ROSEN H., MICHEL B.R. Redundant contribution of myeloperoxidase- dependent systems to neutrophil-mediated killing of Escherichia coli. Infect. Immun., 1997, 65, 4173-7178.
120. SAMPSON J.B., YE Y., ROSEN H., BECKMANN J.S. Myeloperoxidase and horseradish peroxidase catalyze tyrosin nitration in proteins from nitrite and hydrogen peroxide. Arch. Biochem. Biophys., 1998, 356, 207-213.
121. SARAN M., BECK-SPEIER I., FELLERHOFF B., BAUER G. Phagocytic killing of microorganisms by radical processes: consequences of the reaction of hydroxyl radicals with chloride yielding chlorine atoms. Free Radic. Biol. Med., 1999, 26, 482-490.
122. SCHOONBROODT S., LEGRAND-POELS S., BESTBELPOMME M., PIETTE J. Activation of the NF-kB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J., 1997, 321, 777-785.
123. SCHULZE-OSTHOFF K., BAUER M., VOGT M., WESSELBORG S., BAEUERLE P.A. Reactive oxygen intermediates as primary signals and second messengers in the activation of transcription factors. In : Forman H.J., Cadenas E. (eds), Oxidative stress and signal transduction. Chapman and Hall : New York, 1997, 32-51.
124. SCHWARTZ M.D., MOORE E.E., MOORE F.A., SHENKAR R., MOINE P., HAENEL J.B., ABRAHAM E. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit. Care Med., 1996, 24, 1285-1292.
125. SEAHORN T.L., GUANT S.D., BERRY C. Blood cell deformability in horses with intestinal colic. Am. J. Vet. Med. Assoc., 1994, 55, 321-324.
126. SEGAL A.W., GEISOW M., GARCIA R., HARPER A., MILLER R. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 1981, 290, 406-409.
127. SEGELMARK M., PERSSON B., HELLMARK T., WIESLANDER J. Binding and inhibition of myeloperoxidase (MPO) : a major function of ceruloplasmin. Clin. Exp. Immunol., 1997, 108, 167-174.
128. SERTEYN D., CAUDRON I., SZOKE M., FONTAINE G., STACQUEZ S., CHEVE D. Diagnosis and prognosis of the surgical intestinal pathologies in horses. Prat. Vét. Equine, 1994, 26, 135-145.
129. th Biennial Meeting of the International Society for Free Radical Research (SFFR 2000), Kyoto 16-20 octobre 2000, Abstract Book p 69.
130. SHEPPERD V.L., HOIDAL J. Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell. Mol. Biol., 1990, 2, 335-340.
131. SHISHIDO N., NAKAMURA S., NAKAMURA M. Dissociation of DNA double strand by hypohalous acids. Redox Report, 2000, 5, 243-247.
132. SITTIPUNT C., STEINBERG K.P., RUZINSKI J.T., MYLES C., ZHU S., GOODMAN R.B., HUDSON L.D., MATALON S., MARTIN T.R. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med., 2001, 163, 503-510.
133. SNYDER J.R., PASCOE J.R., OLANDER H.J., SPIER S.J., MEAGHER D.M., BLEIFER D.R. Strangulating volvulus of the ascending colon in horses. J. Am. Vet. Med. Assoc., 1989, 195, 757-764.
134. SNYDER J.R., PASCOE J.R., OLANDER H.J., HARMON F.A., HINDS D.M., VATISTASA N.J., TYLER W.S. Ultrastructural mucosal injury after experimental ischemia of the ascending colon in horses. Am. J. Vet. Res., 1992, 53, 1917-1924.
135. SONG M., SANTANAN N. Increased myeloperoxidase and lipid peroxide-modified protein in gynecological malignancies. Antioxid. Redox Signal, 2001, 3, 1139-1146.
136. STENDAHL O., COBLE B.I., DAHLGREN C., HED J., MOLIN L. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J. Clin. Invest., 1984, 73, 366-373.
137. SUTER P.M., SUTER S., GIRARDIN E., ROUX-LOMBARD P., GRAU G.E., DAYER J.M. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis., 1992, 145, 1016-1022.
138. SUZUKI Y.J., FORMAN H.J., SEVANIAN A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med., 1997, 22, 269-285.
139. TAUROG A., DORRIS M.L. Myeloperoxidase-catalyzed iodination and coupling. Arch. Biochem. Biophys., 1992, 296, 239-246.
140. THANNICKAL V.J., FANBURG B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol., 2000, 279, L1005-L1028.
141. THOMAS E.L., JEFFERSON M.M., LEARN D.B., KING C.C., DABBOUS M. Myeloperoxise-catalyzed chlorination of histamine by stimulated neutrophils. Redox Report, 2000, 5, 191-196.
142. TOBLER A., KOEFFLER H.P. Myeloperoxidase: localization, structure, and function. In: Harris G.R. (ed), Blood cell biochemistry 3. Lymphocytes and granulocytes. Plenum Press: New York, 1991, 255-288.
143. TOBLER A., MILLER C.W., JOHNSON K.R., SELSTED M.E., ROVERA G., KOEFFLER H.P. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J. Cell Physiol., 1988, 136, 215-225.
144. TRAWEEK S.T., LIU J., BRAZIEL R.M., JOHNSON R.M., BYRNES R.K. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hydridization. Diagn. Mol. Pathol., 1995, 4, 212-219.
145. VAN DALEN J., WINTERBOURN C., SENTHILMOHAN R., KETTLE A.J. Nitrite as a substrate and inhibitor of myeloperoxidase. J. Biol. Chem., 2000, 275, 11638-11644.
146. TRIM C.M., BARTON M.H., QUANDT J.E. Plasma endotoxin concentrations in anesthetized horses with colic. Vet. Surgery, 1997, 26, 2, 163.
147. VAN DER VLIET A., EISERICH J., HALLIWELL B., CROSS C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. J. Biol. Chem., 1997, 272, 7617-7625.
148. VAN DER VLIET A., EISERICH J.P., SHIGENAGA M.K., CROSS C.E. Reactive nitrogen species and tyrosine nitration in the respiratory tract. Epiphenomena or a pathophysiological mechanism of disease? Am. J. Respir. Crit. Care Med., 1999, 160, 1-9.
149. WEIL S.C., ROSNER G.L., REID M.S., CRISHOLM R.L., LEMONS R.S., SWANSON M.S., CARRINO J.J., DIAZ M.O., LE BEAU M.M. Translocation and rearrangement of myeloperoxidase gene in acute promyelocytic leukemia. Science, 1988, 240, 790-792.
150. WEILAND J.E., DAVIS W.B., HOLTER J.F., MOHAMMED J.R., DORINSKY P.M., GADEK J.E. Lung neutrophils in the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 1986, 133, 218-225.
151. WEISS S.J. Tissue destruction by neutrophils. New Engl. J. Med., 1989, 320, 365-376.
152. WEISS S.J., PEPPIN G., ORTIZ X., RAGSDALE C., TEST S.T. Oxidative autoactivation of latent collagenase by human neutrophils. Science, 1985, 227, 747-749.
153. WHITE N.A., MOORE J.N., TRIM C.M. Mucosal alterations in experimentally induced small intestinal strangulation obstruction in ponies. Am. J. Vet. Res., 1980, 41, 193-198.
154. WHITMAN S.C., HAZEN S.L., MILLER D.B., HEGELE R.A., HEINECKE J.W., HUFF M.W. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenyl-acetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 1238-1249.
155. 2 and chloride. Biochem. J., 1985, 228, 583-592.
156. WINTERBOURN C.C., BRENNAN S.O. Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem. J., 1997, 326, 87-92.
157. WINTERBOURN C.C., KETTLE A.J. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic. Biol. Med., 2000, 29, 403-409.
158. WRIGHT C.D., NELSON R.D. Candidacidal activity of myeloperoxidase: characterization of myeloperoxidase-yeast complex formation. Biochem. Biophys. Res. Commun., 1988, 154, 809-817.
159. YAMADA M., YOSHIDA M., HASHINAKA K. Identification of transcriptional cis-elements in introns 7 and 9 of the myeloperoxidase gene. J. Biol. Chem., 1993, 268, 13479-13485.
160. YARBROUGH J.B., SNYDER J.R., HARMON F.A., O'CONNELL K.A. Evaluation of myeloperoxidase concentrations in experimentally induced equine colonic ischemia and reperfusion. Equine Vet., 1994, 26, 67-69.
161. ZABUCCHI G., SORANZO M.R., MENEGAZZI R., BERTONCIN P., NARDON E., PATRIARCA P. Uptake of human eosinophil peroxidase and myeloperoxidase by cells involved in the inflammatory process. J. Histochem. Cytochem., 1989, 37, 499-508.
162. ZAKI S.R., AUSTIN G.E., SWAN D.C., HOOPER W.C., GREER P.W., EVATT B.L., CHAN W.C. Studies of myeloperoxidase gene expression at the cellular level by in situ hybridization. Leukemia, 1990, 4, 813-818.
163. ZHANG R., BRENNAN M.L., FU X., AVILES R.J., PEARCE G.L., PENN M.S., TOPOL E.J., SPRECHER D.L., HAZEN S.L. Association between myeloperoxidase levels and risk of coronary artery disease. J. Am. Med. Assoc., 2001, 286, 2136-2142.
164. ZHAO W.G., REGMI A., AUSTIN E.D., BRAUN J.E., RACINE M., AUSTIN G.E. Cis-elements in the promoter region of the human myeloperoxidase (MPO) gene. Leukemia, 1996, 10, 1089-1093.